ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 105 filers reported holding ENZO BIOCHEM INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $3,000 | -40.0% | 620 | 0.0% | 0.00% | – |
| Q4 2017 | $5,000 | -64.3% | 620 | -54.4% | 0.00% | – |
| Q3 2017 | $14,000 | +75.0% | 1,360 | +82.6% | 0.00% | – |
| Q2 2017 | $8,000 | +33.3% | 745 | 0.0% | 0.00% | – |
| Q1 2017 | $6,000 | +20.0% | 745 | 0.0% | 0.00% | – |
| Q4 2016 | $5,000 | +25.0% | 745 | 0.0% | 0.00% | – |
| Q3 2016 | $4,000 | 0.0% | 745 | 0.0% | 0.00% | – |
| Q2 2016 | $4,000 | +33.3% | 745 | 0.0% | 0.00% | – |
| Q1 2016 | $3,000 | 0.0% | 745 | 0.0% | 0.00% | – |
| Q4 2015 | $3,000 | -25.0% | 745 | -41.3% | 0.00% | – |
| Q3 2015 | $4,000 | 0.0% | 1,270 | 0.0% | 0.00% | – |
| Q2 2015 | $4,000 | +300.0% | 1,270 | +195.3% | 0.00% | – |
| Q1 2015 | $1,000 | -99.4% | 430 | -98.9% | 0.00% | -100.0% |
| Q4 2014 | $167,000 | -22.0% | 37,675 | -9.3% | 0.00% | 0.0% |
| Q3 2014 | $214,000 | +1.4% | 41,545 | +3.5% | 0.00% | 0.0% |
| Q2 2014 | $211,000 | +15.9% | 40,145 | -8.1% | 0.00% | 0.0% |
| Q1 2014 | $182,000 | – | 43,685 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,436,771 | $7,822,000 | 10.43% |
| VIEX Capital Advisors, LLC | 1,736,087 | $5,573,000 | 8.96% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $16,615,000 | 4.19% |
| AMH Equity Ltd | 596,742 | $1,916,000 | 2.66% |
| Potomac Capital Management, Inc. | 208,000 | $668,000 | 0.59% |
| Agate Pass Investment Management, LLC | 24,292 | $78,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $804,000 | 0.05% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $82,000 | 0.05% |
| Corsair Capital Management | 58,657 | $188,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 319,500 | $1,026,000 | 0.02% |